Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Axogen, Inc.
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
November 07, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
October 24, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
September 06, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
September 03, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Announces New Leadership Appointments
August 08, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
July 23, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
July 01, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
June 24, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
May 28, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
May 16, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
May 14, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc Reports First Quarter 2024 Financial Results
May 02, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
April 29, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
April 16, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
March 05, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
February 13, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 02, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
January 18, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
January 04, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025
January 04, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Announces Promotions on Research and Development Team
January 04, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
December 26, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AMWL
AXGN
Axogen Announces Transition of Finance Team Leadership
December 06, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Reports 2023 Third Quarter Financial Results
November 07, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023
October 18, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™
September 05, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen to Participate at Upcoming Investor Conferences
August 31, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
